Abbott Laboratories
 | |
| Successor | AbbVie  |
|---|---|
| Revenue | 43,653,000,000 United States dollar (2022) |
| 8,362,000,000 United States dollar (2022) | |
| 6,933,000,000 United States dollar (2022) | |
The Abbott Laboratories[1] are an American pharmaceuticals and health care company. They have 90,000+ employees in over 130 countries. The headquarters are in North Chicago, Illinois. This organization was established by Wallace Calvin Abbott in 1888. Abbott's product line includes pharmaceuticals, nutritional, diagnostics, and vascular products.
The company has made drugs for rheumatoid arthritis, diabetes and other conditions. The company makes glucose monitoring devices for diabetics.
According to the Reuters report, Abbott acquired Alere for $4.48 billion, in April 2017.[2]
In September 2017, Abbott announced that it has received Food and Drug Administration clearance for a consumer version of its Freestyle Libre flash glucose monitor, which does not require people with diabetes to routinely prick their fingers to check the glucose levels.[3][4]
Drugs[change | change source]
References[change | change source]
- ↑ "ABT Stock Price & News - Abbott Laboratories - Wall Street Journal". quotes.wsj.com. Retrieved 2017-10-19.
- ↑ "Abbott Laboratories is buying Alere for $4.48 billion". Business Insider. Retrieved 2017-10-19.
- ↑ "Abbott Labs' Billion-Dollar Product". Retrieved 2017-10-19.
- ↑ Schencker, Lisa. "Abbott wins FDA approval for diabetes device that doesn't require routine finger pricks". chicagotribune.com. Retrieved 2017-10-19.
| International | |
|---|---|
| National | |